Cargando…
Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis
In-process control (IPC) is an important task during chemical syntheses in pharmaceutical industry. Despite the fact that each chemical reaction is unique, the most common analytical technique used for IPC analysis is high performance liquid chromatography (HPLC). Today, the so-called “Quality by De...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226502/ https://www.ncbi.nlm.nih.gov/pubmed/34201410 http://dx.doi.org/10.3390/molecules26123505 |
_version_ | 1783712302160150528 |
---|---|
author | Kormány, Róbert Rácz, Norbert Fekete, Szabolcs Horváth, Krisztián |
author_facet | Kormány, Róbert Rácz, Norbert Fekete, Szabolcs Horváth, Krisztián |
author_sort | Kormány, Róbert |
collection | PubMed |
description | In-process control (IPC) is an important task during chemical syntheses in pharmaceutical industry. Despite the fact that each chemical reaction is unique, the most common analytical technique used for IPC analysis is high performance liquid chromatography (HPLC). Today, the so-called “Quality by Design” (QbD) principle is often being applied rather than “Trial and Error” approach for HPLC method development. The QbD approach requires only for a very few experimental measurements to find the appropriate stationary phase and optimal chromatographic conditions such as the composition of mobile phase, gradient steepness or time ([Formula: see text]), temperature (T), and mobile phase pH. In this study, the applicability of a multifactorial liquid chromatographic optimization software was studied in an extended knowledge space. Using state-of-the-art ultra-high performance liquid chromatography (UHPLC), the analysis time can significantly be shortened. By using UHPLC, it is possible to analyse the composition of the reaction mixture within few minutes. In this work, a mixture of route of synthesis of apixaban was analysed on short narrow bore column (50 × 2.1 mm, packed with sub-2 µm particles) resulting in short analysis time. The aim of the study was to cover a relatively narrow range of method parameters ([Formula: see text] , T, pH) in order to find a robust working point (zone). The results of the virtual (modeled) robustness testing were systematically compared to experimental measurements and Design of Experiments (DoE) based predictions. |
format | Online Article Text |
id | pubmed-8226502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82265022021-06-26 Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis Kormány, Róbert Rácz, Norbert Fekete, Szabolcs Horváth, Krisztián Molecules Article In-process control (IPC) is an important task during chemical syntheses in pharmaceutical industry. Despite the fact that each chemical reaction is unique, the most common analytical technique used for IPC analysis is high performance liquid chromatography (HPLC). Today, the so-called “Quality by Design” (QbD) principle is often being applied rather than “Trial and Error” approach for HPLC method development. The QbD approach requires only for a very few experimental measurements to find the appropriate stationary phase and optimal chromatographic conditions such as the composition of mobile phase, gradient steepness or time ([Formula: see text]), temperature (T), and mobile phase pH. In this study, the applicability of a multifactorial liquid chromatographic optimization software was studied in an extended knowledge space. Using state-of-the-art ultra-high performance liquid chromatography (UHPLC), the analysis time can significantly be shortened. By using UHPLC, it is possible to analyse the composition of the reaction mixture within few minutes. In this work, a mixture of route of synthesis of apixaban was analysed on short narrow bore column (50 × 2.1 mm, packed with sub-2 µm particles) resulting in short analysis time. The aim of the study was to cover a relatively narrow range of method parameters ([Formula: see text] , T, pH) in order to find a robust working point (zone). The results of the virtual (modeled) robustness testing were systematically compared to experimental measurements and Design of Experiments (DoE) based predictions. MDPI 2021-06-08 /pmc/articles/PMC8226502/ /pubmed/34201410 http://dx.doi.org/10.3390/molecules26123505 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kormány, Róbert Rácz, Norbert Fekete, Szabolcs Horváth, Krisztián Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title | Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title_full | Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title_fullStr | Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title_full_unstemmed | Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title_short | Development of a Fast and Robust UHPLC Method for Apixaban In-Process Control Analysis |
title_sort | development of a fast and robust uhplc method for apixaban in-process control analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226502/ https://www.ncbi.nlm.nih.gov/pubmed/34201410 http://dx.doi.org/10.3390/molecules26123505 |
work_keys_str_mv | AT kormanyrobert developmentofafastandrobustuhplcmethodforapixabaninprocesscontrolanalysis AT racznorbert developmentofafastandrobustuhplcmethodforapixabaninprocesscontrolanalysis AT feketeszabolcs developmentofafastandrobustuhplcmethodforapixabaninprocesscontrolanalysis AT horvathkrisztian developmentofafastandrobustuhplcmethodforapixabaninprocesscontrolanalysis |